Sabra Health Care REIT (NASDAQ:SBRA) Releases Earnings Results

Sabra Health Care REIT (NASDAQ:SBRA) announced its quarterly earnings data on Wednesday. The real estate investment trust reported $0.36 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.36, Zacks reports. Sabra Health Care REIT had a net margin of 14.20% and a return on equity of 3.51%. Sabra Health Care REIT updated its FY 2025 guidance to 1.430-1.460 EPS.

Sabra Health Care REIT Price Performance

Shares of NASDAQ SBRA opened at $16.55 on Thursday. The stock has a market cap of $3.92 billion, a P/E ratio of 40.37, a P/E/G ratio of 1.98 and a beta of 1.25. Sabra Health Care REIT has a twelve month low of $13.31 and a twelve month high of $20.03. The stock has a 50 day moving average of $16.90 and a two-hundred day moving average of $17.63. The company has a current ratio of 4.16, a quick ratio of 4.16 and a debt-to-equity ratio of 0.90.

Sabra Health Care REIT Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, February 28th. Shareholders of record on Friday, February 14th will be given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 7.25%. The ex-dividend date of this dividend is Friday, February 14th. Sabra Health Care REIT’s dividend payout ratio (DPR) is 292.68%.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on SBRA shares. Citizens Jmp upgraded Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 7th. Mizuho reiterated a “neutral” rating and issued a $20.00 price objective on shares of Sabra Health Care REIT in a report on Thursday, December 5th. Truist Financial cut Sabra Health Care REIT from a “buy” rating to a “hold” rating and decreased their target price for the stock from $18.00 to $17.00 in a research note on Friday, January 17th. Finally, JMP Securities upgraded shares of Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 price target on the stock in a research note on Tuesday, January 7th. Three investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $18.86.

Sabra Health Care REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.